IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2.

Source:http://linkedlifedata.com/resource/pubmed/id/14607902

J. Immunol. 2003 Nov 15 171 10 5051-63

Download in:

View as

General Info

PMID
14607902